Mundo: Neuromod Publishes Results of Second Large Scale Clinical Trial for Tinnitus in Top-Tier Scientific Journal, Shows Great

Lenire is the first non-invasive bimodal neuromodulation tinnitus treatment device shown to soothe and relieve tinnitus in a large-scale clinical trial4. Lenire has CE-mark certification for the treatment of tinnitus under the supervision of an appropriately qualified healthcare professional in Europe. Further details about Lenire including a list of providers can be found at www.lenire.com. About Nature – Scientific Reports

Scientific Reports is an open access journal publishing original research from across all areas of the natural sciences, psychology, medicine and engineering and a member of the Nature family of research journals. Scientific Reports is the 6th most-cited journal in the world, with more than 540,000 citations in 20206, and receives widespread attention in policy documents and the media.

Connect with Neuromod Devices Ltd:

LinkedIn: linkedin.com/company/neuromod

Twitter: twitter.com/NeuromodDevices

Neuromod Devices website: neuromoddevices.com

Lenire website: lenire.com

References

1. Conlon et al., Different bimodal neuromodulation settings reduce tinnitus symptoms in a large randomized trial, Sci Rep, https://doi.org/10.1038/s41598-022-13875-x (2022).

2. Baguely et al., Tinnitus, The Lancet (2013), https://www.sciencedirect.com/science/article/pii/S0140673613601427.

3. McCormack, A., Edmondson-Jones, M., Somerset, S. & Hall, D. A systematic review of the reporting of tinnitus prevalence and severity. Hear Res. 337, 70–79. https://doi.org/10.1016/j.heares.2016.05.009 (2016).

4. Conlon et al., Sci. Transl. Med. 12, eabb2830 (2020).

5. As measured by Tinnitus Handicap Inventory (THI).

6. 2020 Journal Citation Reports® Science Edition (Clarivate Analytics, 2021).

Photo – https://mma.prnewswire.com/media/1850706/Neuromod_Devices_1.jpg

Photo — https://mma.prnewswire.com/media/1850705/Neuromod_Devices_2.jpg

PDF — https://mma.prnewswire.com/media/1850707/Neuromod_Devices.pdf

For more information, please contact:

Neil Doyle

Global Director of Marketing

Neuromod Devices

+353 85 822 9021

neil.doyle@neuromoddevices.com